Market Tracker

04/24 7:03am ET

Celgene Corp (NASDAQ:CELG)

144.82
Data as of Apr 23
 -1.82 / -1.24%
Today’s Change
110.53
Today|||52-Week Range
174.66
-14.29%
Year-to-Date

Today’s Trading

Previous close146.64
Today’s open148.09
Day’s range-- - --
Volume3,409,514
Average volume (3 months)3,928,350
Market cap$56.8B
Dividend yield--
Data as of 04/23/2014

Growth & Valuation

Earnings growth (last year)+2.12%
Earnings growth (this year)+21.88%
Earnings growth (next 5 years)+25.70%
Revenue growth (last year)+19.49%
P/E ratio43.0
Price/Sales10.78
Price/Book10.26

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories0.000.00%
LLYEli Lilly and Co-0.47-0.78%
VRXValeant Pharmaceutic...-2.18-1.61%
ABBVAbbVie Inc+0.13+0.26%
Data as of 04/23/2014

Financials

Last reporting dateApril 24, 2014
EPS forecast (this quarter)$1.65
Annual revenue (last year)$6.5B
Annual profit (last year)$1.4B
Net profit margin22.36%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert J. Hugin
Chief Operating Officer &
Executive Vice President
Perry A. Karsen
Corporate headquarters
Summit, New Jersey

Forecasts